Several positions are open! Check further information from the links below.
1. Doctoral Researcher (MSCA), Generation and optimization of oncolytic viruses for treatment of GBM
2. Doctoral Researcher (MSCA), Generation and tracking of armed rADV with imaging reporter genes
3. Doctoral Researcher (MSCA), Assessing the Immunological Response of Oncolytic Virus Nanoplatforms
Apply latest by 28.5.2026
Apply latest by 8.5.2026
We are seeking a highly motivated Research Technician / Laboratory Manager to join our collaborative, multidisciplinary research team. Our work focuses on understanding aging-related genetic changes in blood cells and their roles in immunology and cancer development. We integrate large population-level cohort analyses with cutting-edge genome editing and single-cell approaches in cell lines and in patient samples.
The research group is led by Mikko Myllymäki, MD, PhD and our research group is located at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki. We are also part of the Translational Immunology Research Program within the Faculty of Medicine.
The successful candidate will join a translational research environment integrating genetics, immunology, cell biology, bioinformatics, and clinical medicine.
Key Responsibilities
• Perform and support routine wet-lab work (such as DNA and RNA based workflows, protein-based workflows, genotyping)
• Culture and maintain leukemia cell lines and induced pluripotent stem cells (iPSCs)
• Assist with sample logistics for single-cell workflows
• Coordinate laboratory reagent orders, maintain sample inventories, and take care of documentation
Comprehensive training will be provided for all techniques and responsibilities.
The position is full-time and fixed-term for three years, with a possibility for extension. A six-month probationary period will be applied (standard in Finnish university employment contracts).
Candidate Requirements
• MSc in a relevant field (e.g., translational medicine, biomedicine, biochemistry, biotechnology, genetics, molecular biology)
• Hands-on experience in experimental laboratory work, particularly cell culture, with careful working style
• Strong organizational skills and attention to detail
• Ability to learn quickly and adapt to changing tasks
• Capability to work both independently and as part of a team
• Fluency in English (written and spoken); Finnish is an advantage but not required
Diversity and equality in work and study cultures are important to us. Therefore, we aim to promote an inclusive university community. We encourage all qualified applicants from diverse backgrounds to apply for our positions.
From this link, you can read about our university’s accessibility and inclusivity.
COME WORK WITH US TO MAKE THE WORLD A BETTER PLACE – TOGETHER!
#helsinkiunicareers
Salary
The salary is based on the job requirement scheme for specialist and support staff in the salary system of Finnish universities, plus a personal performance component. The typical starting gross salary for comparable UH laboratory/research technician roles is approximately €2,600–€3,200/month (depending on duties and experience).
Application Details
The position is available immediately, and we encourage candidates to apply as soon as possible.
Please submit
• A CV
• A motivation letter describing your interest in the position and how your background matches the requirements
Applications should be submitted through the application portal.
We value authentic, self-made applications over those generated by artificial intelligence. Please send us an application that you have crafted yourself, reflecting your own voice and thoughts. Applications generated by AI do not meet our expectations.
Deadline: May 8, 2026
Note: The position will be filled as soon as a suitable candidate is identified.
For inquiries, please contact: mikko.myllymaki(at)helsinki.fi
Apply latest by 13.5.2026
The newly established Finnish Centre of Excellence in Immune – Endothelial Interfaces (IMMENs) invites applications for a fixed-term (2-years) position of a
Doctoral Researcher
The successful candidate will work in the research group of Dr. Kari Vaahtomeri at the Faculty of Medicine, University of Helsinki.
Scientific context
IMMENs, composed of research groups at the University of Helsinki (director Dr. Taija Mäkinen and Dr. Kari Vaahtomeri) and Åbo Akademi in Turku (Dr. Cecilia Sahlgren and Dr. Guillaume Jacquemet), investigates the role of lymphatic vessel endothelium in controlling immune responses. Current evidence shows that much of immune regulation occurs locally at the site of inflammation. Recent studies have revealed important crosstalk between lymphatic endothelium and immune cells, resulting in phenotypic changes that control immune cell trafficking, fate and function. IMMENs will develop novel experimental approaches to uncover the mechanisms and therapeutic potential of lymphatic endothelial immunomodulation in homeostasis, inflammation and tumorigenesis using in vivo genetic mouse models, advanced live and intravital imaging, engineered microchip models, primary cell co-culture systems and novel microscopy and analysis methods. In this context, Vaahtomeri laboratory addresses fundamental cell biology mechanisms of cell migration/interactions.
Who are we looking for
We are looking for candidates with a strong background in life sciences (for example, cell biology, biochemistry or mouse models). The candidate should be highly motivated to investigate key open questions in the fields of:
At the pre-doctoral level, previous experience in cell biology, vascular biology, mouse models, immunology or high-end imaging approaches is considered an advantage.
Doctoral Researcher must obtain the right to pursue doctoral studies at the University of Helsinki within the trial period of six months. Candidates should be able to demonstrate abstract thinking as well as the potential to develop and pursue scientific projects in the fields relevant for this call. Furthermore, the candidate should have excellent communication skills in English and the ability to work in an international environment.
What we offer
The initial appointment is for 2 years and includes a possibility for extension upon success in doctoral research. The position will be filled immediately upon identification of suitable candidates. The starting date is negotiable. Salary will be commensurate with qualifications and experience based on the University of Helsinki guidelines. The chosen applicant is expected to reside in Finland while employed by the University of Helsinki.
The work is supervised by Dr. Kari Vaahtomeri and takes place in the context of the active research community of IMMENs groups. The research group has prominent international connections and is located at the medical campuses in the University of Helsinki. The immediate research environment provides state-of-the-art facilities, cutting-edge expertise in vascular-, tumor-, immunological- and stem cell biology, and great synergy with renowned research groups.
More information on the IMMENS and Vaahtomeri research group can be found here:
https://www.helsinki.fi/en/researchgroups/immune-endothelial-interfaces
https://www.helsinki.fi/en/researchgroups/cell-communication
How to apply
Please submit your application as a single PDF file through the University of Helsinki Recruitment System by clicking the “Apply now” button.
Applicants who are already employees of the University of Helsinki are requested to submit their application via the ”Employee Login” button.
Please attach the following documents as a single PDF file:
For more information on the position and specific projects, please contact Dr. Kari Vaahtomeri (kari.vaahtomeri (at) helsinki.fi).
If you need technical support with the recruitment system or additional information about the application process, please contact HelsinkiUni Help, uni-help (at) helsinki.fi.
The closing date for the applications is on Wednesday the 13th of May 2026.
Recent relevant publications:
Liaqat et al. “Spatially targeted chemokine exocytosis guides transmigration at lymphatic endothelial multicellular junctions”. The EMBO Journal. 2024 Aug;43(15):3141-3174. doi: 10.1038/s44318-024-00129-x.
Can Ucar et al. ”Self-organized and directed branching results in space-filling coverage in developing dermal lymphatic networks”. Nat Commun. 2023 Sep 21;14(1):5878. doi: 10.1038/s41467-023-41456-7.
https://oulunyliopisto.varbi.com/fi/what:job/jobID:890108
Apply latest by 31.1.2026
The University of Oulu is a multidisciplinary, international research university, with about 4000 employees who produce new knowledge based on high-standards research and provide research based education to build a more sustainable, smarter, and more humane world. The University of Oulu community has about 17,000 people in total. Our northern scientific community operates globally and creates conditions for the emergence of innovations.
to join the Intestinal Signaling and Epigenetics research group led by Associate Professor Keijo Viiri in the Faculty of Biochemistry and Molecular Medicine.
This position is part of the HEALTH-DIMENSIONS (Profi 8) research programme, a national profiling action funded by the Research Council of Finland. The programme focuses on ”Multidimensional Big Data and Life-Course Health,” with a specific emphasis on molecular-level mechanistic validation of diseases.
Think of the human body as a complex computer system. Celiac disease is like a software glitch triggered by an external input (dietary gluten) that causes the hardware (the intestine) to malfunction. This research project acts as a system diagnostic—examining the “code” (functional epigenetics) and the “power supply” (metabolism) to identify a “patch” (targeted therapy) that restores the system to its normal state. Above all, this project champions discovery science—uncovering fundamental principles that transcend disease-specific boundaries and generate knowledge with transformative potential across diverse health challenges.
The successful candidate will contribute to an interdisciplinary research environment that bridges clinical data with fundamental molecular biology. The project aims to understand the root causes of intestinal damage and develop personalized treatment strategies for autoimmune conditions.
Key research themes include:
To succeed in this position, we require:
We also appreciate:
The position is fixed-term for three years. Salary is based on levels 2–4 of the demand level chart for teaching and research staff at Finnish universities. In addition, a personal performance component will be paid, with a typical starting gross salary between €2,600 and €2,900 per month. A trial period of 6 months is applied for the position.
Interested? If yes, please apply by 31.1.2026 (23:59 Finnish local time) through our recruitment system.
The application must be written in English and include the following:
The eligible applicants fitting best in the profile expected for the position will be invited to an on-site or remote interview. All applicants will be notified during the selection process.
We welcome applicants from all backgrounds, such as people of different ages, genders, and linguistic, cultural, or minority groups.
If you have any further questions, please contact Associate Professor Keijo Viiri, keijo.viiri@oulu.fi
Apply latest by 9.11.
Orion Corporation is a well-established, financially stable pharmaceutical company operating in more than 35 countries, including recently established R&D hubs in NYC, USA and Cambridge, UK. In the Pain Therapy Area, we focus on targets modulating sensory neuron hyperexcitability and neuro-immune interactions. Additionally, we are looking to expand our research into inflammatory diseases. As the current Head of Pain Research is retiring, we are seeking new talent to shape the future of the Therapy Area.
We are seeking a visionary and strategic leader to head our Pain and Inflammation Research within the Pain Therapy area. This role is pivotal in shaping the future of pain and inflammation therapeutics by driving scientific innovation, strategic collaborations, and portfolio development. The successful candidate will lead a group of over 20 dedicated scientists and research associates, manage cross-functional teams, and foster partnerships with academia and industry to advance our mission of delivering transformative treatments for pain and inflammation-related diseases.
Key Responsibilities Strategic Leadership & Portfolio Development
Scientific and Collaborative Leadership
Cross-functional Collaboration
People Leadership & Development
External Engagement
What We Offer:
We offer a dynamic and innovative research environment where you’ll have the opportunity to shape the future of the Therapy Area. Our workplace culture is built on mutual respect, continuous learning, and shared values, fostering a sense of belonging and purpose. With a collaborative culture that spans global teams, we support meaningful connections and shared success. In addition to engaging work, we provide competitive compensation and a comprehensive benefits package designed to support your personal and professional growth.
At Orion Pharma, your work creates true impact and well-being for our customers, patients and society at large. Our culture of friendliness, respect, mutual appreciation and diversity creates a safe working environment where you can strive for excellence. We offer a wealth of career paths and development opportunities that support the development of innovative solutions and improving the quality of life.
Please visit our website to find further information about our values and Orion as an employer https://www.orion.fi/en/careers/orion-as-an-employer/ .
Orion Pharma will support relocation. You can work flexibly in a hybrid model in accordance with Orion’s relevant guidelines.
Our expectations
Additional Information
If you are the person we are looking for, please submit your cover letter and CV by 9 th November 2025.
#LI-ORION
Approved medical examination which also includes drug testing is required prior to the employment.
Orion Pharma’s pharmaceutical innovations are created within its R&D organization. We employ around 400 top professionals in the field of drug discovery and development. We work globally: in Espoo and Turku in Finland, in Cambridge and Nottingham in England and in New York, NY, USA. Orion R&D and the Innovative Medicines business division are dedicated to making a transformation to become a global player in the pain and oncology therapy areas.
Apply latest by 24.11.
The immunology research group “Leukocyte Traffic and the Immune Response”, led by Professor Marko Salmi, invites applications for two fixed-term postdoctoral researcher positions at the Faculty of Medicine, University of Turku. The positions are funded by the Research Council of Finland and the Jane and Aatos Erkko Foundation.
Our group focuses on understanding how protective and pathogenic innate and adaptive immune responses are initiated during inflammation, cancer, and vaccination (Salmilab). Key areas of interest include the trafficking of antigens from peripheral tissues to lymph nodes via lymphatic vessels, the role of lymph node stromal cells in immune responses, myeloid leukocyte differentiation and function, and immunological biomarkers of inflammation and cancer. We employ advanced microscopy-based imaging, flow cytometry, single-cell omics, and functional immunological assays in experimental models, complemented by analyses of patient samples and close collaboration with clinicians. Our group operates within the MediCity Research Laboratory at the Faculty of Medicine, University of Turku, and belongs to the InFLAMES Flagship of the Research Council of Finland, a national initiative advancing translational immunological research.
We are looking for two motivated postdoctoral researchers to study the initiation of immune responses in lymphoid tissues and their targeted pharmacological modulation.
In one project, we investigate how free antigens in lymph enter the lymph node parenchyma and influence stromal cells during different phases of immune response. In the other project, our goal is to develop new strategies to deliver antibody-based immunoregulatory drugs specifically to lymph nodes in cancer and inflammatory diseases.
Both projects aim to uncover cellular and molecular mechanisms underlying lymph node function.
Apply between 27 October 2025 and 24 November 2025 16:00 (Europe/Helsinki)
Requirements / Qualifications / You should have
Essential qualifications:
• Doctoral degree in immunology, (bio)medicine, biology, or another relevant life science field
• Proven experience in laboratory-based experimental work
• Ability to work independently and proactively
• Excellent teamwork and communication skills
• Excellent written and spoken English
• Strong knowledge and skills in immunology, stromal/matrix biology, or cancer biology
• Solid scientific publication record
Additional merits:
• Experience in single-cell omics, bioinformatics, imaging, flow cytometry, or in vivo inflammation models
We value equality and diversity in our community and encourage applicants from diverse backgrounds. The regulations described in the University’s Rules of Procedures apply to all postdoctoral researcher jobs.
We offer responsible and inspiring research tasks and the opportunity to develop your expertise and career in a multidisciplinary, dynamic and international environment. You will work as part of a professional and enthusiastic team and within the InFLAMES Flagship, involving around 60 research groups across disciplines.
You will also have access to training and networking opportunities through university-level immunological programs such as the IMMUFELLOW MSCA COFUND Postdoctoral Programme and the National Doctoral Training Pilot (ImmuDocs). You will benefit from the state-of-the-art research infrastructure of the Turku Bioscience Centre, located in the same building as MediCity.
Health, diagnostics, drug development, and immunology are profiling areas of the University of Turku. High-quality basic research combined with close collaboration with the university hospital creates a strong foundation for international excellence.
We also prioritize well-being and work–life balance. Learn more on our Welcome to Work with Us page.
The European Commission has awarded the University of Turku the right to use the HR Excellence in Research quality label. The label is a token of the University’s commitment to continuous development of the position and working conditions of researchers according to the guidelines set forth in the European Charter for Researchers.
The university offers good support and orientation for international hires. Please learn more about the Finnish culture and relocation to Finland:
The University of Turku is among the top of the world’s universities in most rankings and among the best universities in the world in certain fields. Our high-quality basic research, a multidisciplinary research profile and close cooperation in research infrastructures creates the basis for international top research. Read more about University of Turku in international university rankings.
The University of Turku has several high-quality research infrastructures required for cutting-edge research. Learn more about the roadmap of research infrastructures and how the research infrastructure and expert teams offer tailored solutions for businesses and organizations.
The salary is determined according to the Finnish university salary system (teaching and research staff category). The starting salary for a postdoctoral researcher is approximately €3,600–4,000 per month, depending on qualifications and experience.
The position starts on 1 January 2026 or as agreed. The position is fixed-term for 2–3 years with a six-month trial period. Continuation beyond the initial term may be negotiated.
Applicants must attach the following documents:
• Degree certificates (in English or Finnish or officially translated)
• Motivation letter (max 1 page)
• Curriculum vitae (max 3 pages)
• List of publications
• List of up to five most important publications with brief description of applicant’s role in each
• Contact details of two referees
Please note that the application form includes one mandatory video question.
For further information about the position, please contact:
For scientific inquiries: Prof. Marko Salmi (marko.salmi@utu.fi)
For recruitment process inquiries: HR Specialist Anne Jackson (anne.jackson@utu.fi)
The InFLAMES Flagship (Innovation Ecosystem based on the Immune System) is a joint organization of the University of Turku and Åbo Akademi University aiming at being an internationally recognized, top-level, immunological research and development cluster that will be globally attractive both for researchers and business partners. We are part of the Academy of Finland’s Flagship Programme.
The Faculty of Medicine is a high level, international and innovative research and education unit in biomedicine, clinical medicine, dentistry and health and nursing sciences, as well as a major social contributor to health promotion, disease genesis, in the research of diagnostics and treatment and in the development of the health service and education system. The faculty provides research-based multidisciplinary undergraduate education in educational programs that educate diverse and critically minded specialists. The research is multidisciplinary and results in new information aimed at promoting the health of the population and better patient care.
The University of Turku is an inspiring and international academic community of 25,000 students and staff in Southwest Finland. We build a sustainable future with multidisciplinary research, education, and collaboration. With us, your work will have a significant impact and relevance in the changing world.
